TrialBritish journal of haematology2013

Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.

Yasuhiro Oki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.